Cargando…

Reply to comment: Month of birth and risk of multiple sclerosis: confounding and adjustments

Detalles Bibliográficos
Autores principales:	Torkildsen, Øivind, Aarseth, Jan, Celius, Elisabeth Gulowsen, Holmøy, Trygve, Kampman, Margitta T, Løken-Amsrud, Kristin Ingeleiv, Midgard, Rune, Myhr, Kjell-Morten, Riise, Trond, Grytten, Nina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2014
Materias:	Reply to Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184690/ https://www.ncbi.nlm.nih.gov/pubmed/25356407 http://dx.doi.org/10.1002/acn3.56

Ejemplares similares

Month of birth and risk of multiple sclerosis: confounding and adjustments
por: Torkildsen, Øivind, et al.
Publicado: (2014)

Level of education and multiple sclerosis risk over a 50-year period: Registry-based sibling study
por: Bjørnevik, Kjetil, et al.
Publicado: (2016)

Inflammation Markers in Multiple Sclerosis: CXCL16 Reflects and May Also Predict Disease Activity
por: Holmøy, Trygve, et al.
Publicado: (2013)

Recent progress in maintenance treatment of neuromyelitis optica spectrum disorder
por: Holmøy, Trygve, et al.
Publicado: (2020)

Alpha-tocopherol and MRI Outcomes in Multiple Sclerosis – Association and Prediction
por: Løken-Amsrud, Kristin I., et al.
Publicado: (2013)

No association of tobacco use and disease activity in multiple sclerosis
por: Kvistad, Silje, et al.
Publicado: (2016)

Association of adverse childhood experiences with the development of multiple sclerosis
por: Eid, Karine, et al.
Publicado: (2022)

Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study
por: Cortese, Marianna, et al.
Publicado: (2015)

Level of education and multiple sclerosis risk after adjustment for known risk factors: The EnvIMS study
por: Bjørnevik, Kjetil, et al.
Publicado: (2016)

Mortality and cause of death in multiple sclerosis in western Norway 1950–2021: a registry-based linkage study
por: Willumsen, Johannes Sverre, et al.
Publicado: (2022)

Abuse and revictimization in adulthood in multiple sclerosis: a cross-sectional study during pregnancy
por: Eid, Karine, et al.
Publicado: (2022)

Ocrelizumab quantitation by liquid chromatography-tandem mass spectrometry
por: Hallin, Erik I., et al.
Publicado: (2022)

Perinatal Depression and Anxiety in Women With Multiple Sclerosis: A Population-Based Cohort Study
por: Eid, Karine, et al.
Publicado: (2021)

High incidence and prevalence of MS in Møre and Romsdal County, Norway, 1950–2018
por: Willumsen, Johannes Sverre, et al.
Publicado: (2020)

Natural Variation of Vitamin D and Neurofilament Light Chain in Relapsing-Remitting Multiple Sclerosis
por: Røsjø, Egil, et al.
Publicado: (2020)

Real-world discontinuation rate of teriflunomide and dimethyl fumarate in multiple sclerosis
por: Norborg, Hilde, et al.
Publicado: (2021)

Safety and efficacy of rituximab as first- and second line treatment in multiple sclerosis – A cohort study
por: Torgauten, Hilde Marie, et al.
Publicado: (2021)

Treatment-resistant immune thrombocytopenic purpura associated with LDN use in a patient with MS
por: Torkildsen, Øivind, et al.
Publicado: (2014)

Reply to Mankowska et al. Comment on “Muth et al. Assessing Critical Flicker Fusion Frequency: Which Confounders? A Narrative Review. Medicina 2023, 59, 800”
por: Muth, Thomas, et al.
Publicado: (2023)

Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations
por: König, Marton, et al.
Publicado: (2023)

Extensive Multiple Sclerosis Reactivation after Switching from Fingolimod to Rituximab
por: Holmøy, Trygve, et al.
Publicado: (2018)

Reply
por: Villa, E, et al.
Publicado: (2001)

In reply:
por: Starčević Čizmarević, Nada, et al.
Publicado: (2021)

The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis
por: Lie, Ingrid Anne, et al.
Publicado: (2022)

The Authors’ Reply
por: Mallik, Sarmila, et al.
Publicado: (2012)

The authors’ reply
por: El-Kannishy, Ghada M.
Publicado: (2018)

The authors’ reply
por: Kim, Hyo Shik, et al.
Publicado: (2017)

Authors’ reply
por: Myrtennäs, Kerstin, et al.
Publicado: (2017)

The author’s reply
por: Park, Chun Soo
Publicado: (2022)

The author’s reply
por: Park, Hyung Joo
Publicado: (2022)

Neurofilament Light Chain as a Biomarker in Multiple Sclerosis
por: Varhaug, Kristin N., et al.
Publicado: (2019)

An Update on Vitamin D and Disease Activity in Multiple Sclerosis
por: Smolders, Joost, et al.
Publicado: (2019)

Employment among Patients with Multiple Sclerosis-A Population Study
por: Bøe Lunde, Hanne Marie, et al.
Publicado: (2014)

Reply to the Comment of G. Feulner
por: Weber, Werner
Publicado: (2011)

In Reply to: Fine Needle Aspiration
por: Ehsanbakhsh, Ali-Reza, et al.
Publicado: (2014)

Reply to the Comment by Littlechild and Isupov
por: Willetts, Andrew, et al.
Publicado: (2017)

Reply to Weiermayer et al. Evidence-Based Human Homeopathy and Veterinary Homeopathy. Comment on “Bergh et al. A Systematic Review of Complementary and Alternative Veterinary Medicine: “Miscellaneous Therapies”. Animals 2021, 11, 3356”
por: Bergh, Anna, et al.
Publicado: (2022)

Reply to “The Carotid Sinus as a Viscometer”
por: Lee, Ui Yun, et al.
Publicado: (2020)

Reply to ‘Management of noncompaction requires optimisation’
por: Gurunathan, Sothinathan, et al.
Publicado: (2019)

Safety of breast feeding during rituximab treatment in multiple sclerosis
por: Rød, Brit Ellen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8p3t1gonnb4bbeqcnc3h9fmbno